Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Companion Diagnostics and Personalized Medicine Market Report 2012: Twease.org

August 28, 2012

ALBANY, N.Y., Aug. 23, 2012 /PRNewswire/ — Twease.org – New Report Added in Pharmaceuticals Reports Database Companion Diagnostics and Personalized Medicine Market Report 2012

This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace. Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population–the field of stratified medicine.

To Browse Full Toc Visit: http://www.twease.org/report/companion-diagnostics-and-personalized-medicine-market-report-2012.htm

Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:

  • All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described–a few have already been developed into CDx and we expect growth in this space
  • Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
  • Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented–Provides an Up-to-Date State of the Industry Describing the Disease Areas being Addressed and Types of Biomarkers Being Deployed
  • Quantitative Market Metrics
  • Quantitative Market Forecast: Market Sizing and Growth Rate
  • Revenue Breakout: Rx versus Dx
  • Targeted Rx and CDx Pricing
  • Publication Hotspot Analyses of the Various Cancer Biomarker Classes for Identifying Niches of Market Opportunity in Various Disease Classes

Related Reports:

Personalized Medicine Market
MicroRNAs and Exosomes Market
MicroRNA Market
MicroRNA Research and Disease Associations
Circulating Tumor Cells

This data-driven characterization of the Companion Diagnostics and Personalized Medicine field is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development–all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans–this Market Report is written and delivered to customers in PowerPoint format.

Extensive Market Analyses Presented in this Report

Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis

  • Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Predictive Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Summary of Pathways to Regulatory Approval of Companion Diagnostics
  • LDTs under CLIA Certification
  • Outcomes with Drugs in Various Disease Classes
  • Percent of Tumor Classes where Tumors are Associated with Characterized Somatic Mutations
  • Companion Diagnostics and Personalized Medicine: Quantitative Market Metrics
  • How Much Does it Cost to Develop a Companion Diagnostic?
  • Precedent for Premium Pricing in Cancer Targeted Therapeutics
  • Pricing of Selected Personalized Medicine Tests
  • Growth of the Personalized Medicine Marketplace: Market Size/Forecast and Growth Rate

Personalized Medicine Industry Landscape: Selected Indications, Biomarkers and Therapeutics

Market Trends and Evolution of the CDx Marketplace

  • Disparities between Rx and CDx Companies
  • Varying Economic Incentives between Rx and Dx Development
  • Increasing Targeted Rx in the Oncology Space and Effect on CDx Development
  • Current Rx/CDx Co-development Programs in Phase III Trials with Listing of Associated Biomarkers
  • Cancer Classes Addressable by CDx
  • Characterization of Molecular Biomarker Classes: Hotspot Analysis of Publications
  • Cancer Biomarkers
  • Oncogenes
  • Tumor Suppressor Genes
  • Non-coding RNAs

Collaborations and Partnering in the CDx Space

  • 2012
  • 2011
  • 2010
  • 2009

Related Reports:

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
Circulating Tumor Cells (CTCs)Market
Cancer Vaccines & Circulating Tumor Cells (CTCs)
Umbilical Cord Blood Banking Market
Single Cell Omics
Adult Stem Cells Market
Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies

About Us

Twease.org is the number one stop for all the latest reports, news and industry information related to pharmaceutical domain. Our database represents a collection which is updated on a daily basis and consists of all major pharmaceutical market research publishers.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
Email: sales@twease.org

Visit: http://www.twease.org/
Buy SWOT: http://www.wpt9.com/

SOURCE Twease.org


Source: PR Newswire